Conquering cancer requires information and dialogue. Our print and online resources make it easy to stay up-to-date on CRI’s role in helping to advance cancer immunotherapy research and treatment. We also offer information especially for patients and their families, as well as for current and prospective donors.
For the latest news, sign up for our e-alerts or subscribe to our blog. You can also read our print publications, view our videos, and access our guides and other resources for patients for more information. If you would like more information, call us at (800) 99-CANCER or send us a message via our Contact Us page.
Our blog features the latest updates from the front lines of cancer immunotherapy, including new scientific and clinical breakthroughs, news stories, and program announcements. Read the latest stories here or go to our blog to see all of our posts and subscribe to receive alerts when new stories are posted.
May 13, 2013
| Brian Brewer
Breakthrough new immune-based cancer treatments are offering patients a real chance at keeping cancer at bay for the long term, experts report in this article from Bloomberg News.
antibody, anti-CTLA-4, anti-PD-1, immunotherapy, Jedd Wolchok, melanoma, metastases, yervoy
May 7, 2013
| Brian Brewer
We made our first formal public announcement today of our newest initiative, Cancer Immunotherapy Awareness Month, taking place in June each year.
awareness, cancer, immunotherapy
May 6, 2013
| Alexandra Mulvey
Today, many up-and-coming CD antigens are joining the classics as promising targets for immune-based drug development as part of a new class of treatment that directly targets immune cell co-stimulatory pathways to boost the immune response against cancer. And many “remixes” have brought the classics in vogue once again.
breast cancer, CD antigens, clinical accelerator, kidney cancer, leukemia, lloyd old, lung cancer, lymphoma, melanoma, ovarian cancer